AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational
Commenting on its operations, William S. Marth, AMRI's President and Chief Executive Officer, said: "We are pleased to report that all suites at our OsoBio Albuquerque aseptic manufacturing facility are fully operational. I would like to acknowledge and thank our colleagues and vendors for their dedicated efforts in remediating the affected manufacturing suite as quickly as possible."
AMRI's OsoBio facility is a provider of cGMP manufacturing and sterile filling of parenteral drugs using specialized technologies, including lyophilization. With its cGMP aseptic filling expertise, OsoBio supports commercial scale production of liquid-filled and lyophilized parenterals. These services are provided for both small molecule drug products as well as biologicals. Oso Biopharmaceutical Manufacturing was acquired by AMRI in July 2014.
Most read news
Organizations
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.